Article Details
Retrieved on: 2025-05-19 13:00:52
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses stock performance related to 'COVID Vaccine', highlighting gains for Sugentech, Daiichi Sankyo, and Shanghai Junshi Biosciences, driven by UBS's increased price target for Daiichi Sankyo.
Article found on: theedgemalaysia.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here